Search results for "Predictive value"

showing 10 items of 927 documents

Diagnostic Accuracy of <sup>13</sup>C-Urea Breath Test in the Diagnosis of <i>Helicobacter pylori</i> Infection in Patients w…

2001

<i>Aims:</i> We investigated the diagnostic properties of the <sup>13</sup>C-urea breath test (<sup>13</sup>C-UBT) prospectively. These are well validated in nonresected patients before and after treatment of <i>Helicobacter pylori</i> infection but not in patients with partial gastric resection due to peptic ulcer disease. <i>Methods:</i> Hospitalized patients with previous gastric resection and indications for upper gastrointestinal endoscopy were recruited for the study. Biopsy specimens were obtained from the fundus mucosa and the gastric remnant adjacent to the gastroenteric anastomosis for histological examination and rapid u…

Breath testmedicine.medical_specialtymedicine.diagnostic_testbiologybusiness.industryUrea breath testStomachmedicine.medical_treatmentGastroenterologyRapid urease testHelicobacter pyloribiology.organism_classificationGastroenterologymedicine.anatomical_structurePredictive value of testsInternal medicineMedicineGastrectomyProspective cohort studybusinessDigestion
researchProduct

Cancer screening and health system resilience: Keys to protecting and bolstering preventive services during a financial crisis

2012

The aim of this paper is to elucidate the rationale for sustaining and expanding cost-effective, population-based screening services for breast, cervical and colorectal cancers in the context of the current financial crisis. Our objective is not only to promote optimal delivery of high-quality secondary cancer prevention services, but also to underline the importance of strengthening comprehensive cancer control, and with it, health system response to the complex care challenges posed by all chronic diseases. We focus primarily on issues surrounding planning, organisation, implementation and resources, arguing that given the growing cancer burden, policymakers have ample justification for e…

BudgetsCancer ResearchEconomic growthNational Health ProgramsCost-Benefit Analysismedia_common.quotation_subjectPopulationPublic policyContext (language use)Population healthFinancial managementPredictive Value of TestsNeoplasmsPreventive Health ServicesCancer screeningHumansMass ScreeningOrganizational ObjectivesMedicinePolicy Makingeducationmedia_commoneducation.field_of_studyGovernmentEvidence-Based Medicinebusiness.industryHealth PolicyEnvironmental resource managementHealth Care CostsHealth PlanningEconomic RecessionOncologyPractice Guidelines as TopicPsychological resiliencebusinessDelivery of Health CareEuropean Journal of Cancer
researchProduct

Unusual Neuroendocrine Differentiation in a Small Round Cell Angiosarcoma: A Potential Histologic Mimicker of Superficial Ewing Sarcoma.

2018

Neuroendocrine differentiation or aberrant expression of neuroendocrine markers is very uncommon in angiosarcomas (AS) and creates a challenging differential diagnosis with other superficial or soft tissue tumors. Herein, we report a new case of superficial AS presenting as a tumor lesion on the little finger of the right hand of a 52-year-old man. The tumor displayed CD56, chromogranin-A, and synaptophysin immunoreactivity. Tumor cells were positive for vascular markers (CD31, FLI1, ERG, D2-40, VE-cadherin, VEGR1,2, and 3), CD99, and EMA, but were negative for S100, CK (AE1/AE3), CK20, polyomavirus, and myogenic (desmin and myogenin) and melanocyte markers (melan-A and HMB45). Ki67 immunos…

CD31MalePathologymedicine.medical_specialtySkin NeoplasmsBiopsyCD99HemangiosarcomaDermatologySarcoma EwingNeuroendocrine differentiationPathology and Forensic MedicineDiagnosis DifferentialFingers030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicinePredictive Value of TestsBiopsymedicineBiomarkers TumorHumansAngiosarcomaIn Situ Hybridization FluorescenceCell Proliferationbiologymedicine.diagnostic_testMerkel cell carcinomabusiness.industryCell DifferentiationGeneral MedicineMiddle Agedmedicine.diseaseImmunohistochemistryCarcinoma Neuroendocrine030220 oncology & carcinogenesisSarcoma Small CellSynaptophysinbiology.proteinSarcomabusinessThe American Journal of dermatopathology
researchProduct

Macrophage-Specific Lipid-Based Nanoparticles Improve Cardiac Magnetic Resonance Detection and Characterization of Human Atherosclerosis

2009

ObjectivesWe sought to determine whether gadolinium (Gd)-containing lipid-based nanoparticles (NPs) targeting the macrophage scavenger receptor-B (CD36) improve cardiac magnetic resonance (CMR) detection and characterization of human atherosclerosis.BackgroundGd-containing lipid-based NPs targeting macrophages have improved MR detection of murine atherosclerosis.MethodsGadolinium-containing untargeted NPs, anti-CD36 NPs, and nonspecific Fc-NPs were created. Macrophages were incubated with fluorescent targeted and nontargeted NPs to determine uptake via confocal microscopy and inductively coupled plasma mass spectroscopy (ICP-MS) quantified Gd uptake. Human aortic specimens were harvested at…

CD36 AntigensGadoliniumCD36Contrast Media030204 cardiovascular system & hematology030218 nuclear medicine & medical imaging0302 clinical medicineHeterocyclic CompoundsMacrophageMacrophage Scavenger Receptorhealth care economics and organizationsCells CulturedMicroscopy Confocalmedicine.diagnostic_testbiologyrespiratory systemImmunohistochemistryLipidsMagnetic Resonance ImagingRadiology Nuclear Medicine and imagingcardiovascular systemAutopsyCardiology and Cardiovascular Medicinetherapeuticscirculatory and respiratory physiologyinorganic chemicalsAortic Diseaseschemistry.chemical_elementmacrophageAortic diseaseArticle03 medical and health sciencesPredictive Value of TestsLipid based nanoparticlesmedicineOrganometallic CompoundsHumansRadiology Nuclear Medicine and imagingcardiovascular diseasesbusiness.industryMacrophagesSpectrophotometry Atomictechnology industry and agricultureMagnetic resonance imagingBiological TransportAtherosclerosischemistryCancer researchbiology.proteinNanoparticlesCD36Cardiac magnetic resonancebusinessJACC: Cardiovascular Imaging
researchProduct

Procalcitonin and C-reactive protein as early predictors of anastomotic leak in colorectal surgery: a prospective observational study.

2013

Although the early diagnosis of anastomotic leak is a key point in reducing its clinical consequences, in daily practice, anastomotic leak diagnosis is often late.The aim of this study was to determine whether procalcitonin and C-reactive protein are good predictors of anastomotic leak in colorectal surgery.This is a prospective observational study.This study was conducted by a specialized colorectal multidisciplinary team of a tertiary teaching hospital.A series of 205 consecutive patients who underwent elective colorectal surgery in a specialized unit was prospectively analyzed. The following data were collected: demographic, surgical, ASA class, POSSUM, and morbidity. During the first 5 …

CalcitoninMalemedicine.medical_specialtyLeakColonCalcitonin Gene-Related PeptideAnastomotic LeakAnastomosisSensitivity and SpecificityProcalcitoninColon surgeryPredictive Value of TestsMedicineHumansPostoperative PeriodProspective StudiesProtein PrecursorsProspective cohort studybiologybusiness.industryC-reactive proteinGastroenterologyRectumGeneral MedicineMiddle AgedColorectal surgerySurgeryC-Reactive ProteinEarly DiagnosisROC CurvePredictive value of testsbiology.proteinFemalebusinessBiomarkersDiseases of the colon and rectum
researchProduct

Why do results conflict regarding the prognostic value of the methylation status in colon cancers? The role of the preservation method.

2012

Abstract Background In colorectal carcinoma, extensive gene promoter hypermethylation is called the CpG island methylator phenotype (CIMP). Explaining why studies on CIMP and survival yield conflicting results is essential. Most experiments to measure DNA methylation rely on the sodium bisulfite conversion of unmethylated cytosines into uracils. No study has evaluated the performance of bisulfite conversion and methylation levels from matched cryo-preserved and Formalin-Fixed Paraffin Embedded (FFPE) samples using pyrosequencing. Methods Couples of matched cryo-preserved and FFPE samples from 40 colon adenocarcinomas were analyzed. Rates of bisulfite conversion and levels of methylation of …

Cancer ResearchBisulfite sequencing[SDV.CAN]Life Sciences [q-bio]/CancerAdenocarcinomaBiologyMLH1lcsh:RC254-282[ SDV.CAN ] Life Sciences [q-bio]/Cancerchemistry.chemical_compound[SDV.CAN] Life Sciences [q-bio]/CancerPredictive Value of TestsBiomarkers TumorGeneticsHumansSulfitesDNA Modification MethylasesAdaptor Proteins Signal TransducingCryopreservationParaffin EmbeddingTumor Suppressor ProteinsNuclear ProteinsReproducibility of ResultsDNA NeoplasmMethylationDNA MethylationPrognosislcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogensMolecular biologydigestive system diseasesNeoplasm ProteinsBisulfiteDNA Repair EnzymesLong Interspersed Nucleotide ElementsPhenotypeOncologyCpG sitechemistrySodium bisulfiteColonic NeoplasmsDNA methylationFeasibility StudiesPyrosequencingCpG IslandsMutL Protein Homolog 1Research Article
researchProduct

Activity of O(6)-methylguanine-DNA methyltransferase in relation to p53 status and therapeutic response in ovarian cancer.

1999

The DNA-repair protein O(6)-methylguanine-DNA methyltransferase (alkyltransferase; MGMT) is a major determinant of resistance of cells to various alkylating cytostatic drugs. Its expression in tissues is highly variable, indicating complex regulatory mechanisms involved. Transfection-mediated expression of wild-type p53 has been shown to negatively regulate basal promoter activity of MGMT in vitro. To elucidate whether p53 is involved in regulation of MGMT in tumor tissue, we examined MGMT expression and the p53 status of 140 primary ovarian carcinomas and analyzed the data as to the correlation between MGMT and p53, as well as the survival response of the patients after chemotherapy. We sh…

Cancer ResearchPathologymedicine.medical_specialtyMethyltransferaseTime FactorsCyclophosphamidemedicine.medical_treatmentBiologyDisease-Free Survivalchemistry.chemical_compoundO(6)-Methylguanine-DNA MethyltransferasePredictive Value of TestsmedicineHumansneoplasmsNeoplasm StagingRetrospective StudiesOvarian NeoplasmsChemotherapyL-Lactate DehydrogenaseCancermedicine.diseaseGenes p53ImmunohistochemistrySurvival Analysisdigestive system diseasesNitrogen mustardCarboplatinOncologychemistryCancer researchFemaleTumor Suppressor Protein p53Ovarian cancermedicine.drugAlkyltransferaseFollow-Up StudiesInternational journal of cancer
researchProduct

Children may not benefit from neuroblastoma screening at 1 year of age. Updated results of the population based controlled trial in Germany

2003

Neuroblastoma is the second most frequent malignancy in childhood. We investigated whether screening for neuroblastoma at 1 year of age reduces the incidence of metastatic disease or mortality. Screening was offered in 6 of the 16 German states from 1995 to 2000 with the remaining states serving as controls. We studied 2,581,188 children in the screening area born between 1994 and 1999 and 2,117,600 in the control area. We compared mortality from neuroblastoma and the incidence of disseminated disease in the two groups. The screened group and the control group had similar rates of stage 4 neuroblastoma and mortality due to neuroblastoma. Comparison of the screened group and the control area…

Cancer ResearchPediatricsmedicine.medical_specialtyPopulationCohort StudiesNeuroblastomaPredictive Value of TestsGermanyNeuroblastomaEpidemiologyHumansMass ScreeningMedicineOverdiagnosiseducationFalse Negative ReactionsMass screeningNeoplasm Stagingeducation.field_of_studybusiness.industryIncidenceIncidence (epidemiology)Infantmedicine.diseaseOncologyScreening for NeuroblastomaChild PreschoolPopulation SurveillancebusinessProgram EvaluationCohort studyCancer Letters
researchProduct

Impact of BMI on Preoperative Axillary Ultrasound Assessment in Patients With Early Breast Cancer

2020

Background The accuracy of axillary ultrasound (AUS) with fine-needle aspiration with varying patient body mass index (BMI) is still unclear. The aim of our study was to evaluate whether the US features of axillary lymph nodes changes with BMI of patients. Patients and methods A retrospective review was performed involving 144 out of 270 patients with early breast cancer who underwent breast surgery with sentinel lymph node biopsy. Diagnostic efficacy of AUS in preoperative axillary nodal staging was assessed in relation to BMI. Results Negative predictive values of AUS for the overweight and obese groups were statistically significantly lower compared to the normal/underweight group (p=0.0…

Cancer Researchmedicine.medical_specialtyAxillary lymph nodesBreast surgerymedicine.medical_treatmentSentinel lymph nodeBreast NeoplasmsOverweightBody Mass Indexaxillary ultrasoundBMIBreast cancerbreast cancerBiopsymedicineHumansUltrasonographymedicine.diagnostic_testpredictive valuebusiness.industryGeneral Medicinemedicine.diseasemedicine.anatomical_structureOncologyCohortAxillaPreoperative PeriodFemaleRadiologymedicine.symptombusinessBody mass index
researchProduct

Prognostic value of International Neuroblastoma Pathology Classification in localized resectable peripheral neuroblastic tumors: a histopathologic st…

2006

Purpose To assess the prognostic value of clinical, biologic, and morphologic data in peripheral neuroblastic tumors, International Neuroblastoma Staging System (INSS) stages 2A and 2B MYCN nonamplified, a multinational protocol entitled Localized Neuroblastoma European Study Group trial 94.01, with a trial of surgery as the only treatment, was initiated in 1995. We present the prognostic value of the revised International Neuroblastoma Pathology Classification (INPC) applied to the patients included in this protocol until its closure in 1999. Materials and Methods A total of 120 neuroblastic tumors from trial patients were reviewed by the European International Society of Pediatric Oncolog…

Cancer Researchmedicine.medical_specialtyPathologyDisease-Free SurvivalNeuroblastomaPredictive Value of TestsNeuroblastomamedicineHumansSurvival analysisGanglioneuroblastomaL-Lactate Dehydrogenasebusiness.industryGanglioneuroblastomaAnatomical pathologymedicine.diseasePrognosisNeuroblastic TumorSurvival AnalysisClinical trialEuropeTreatment OutcomeOncologyPredictive value of testsHistopathologybusinessJournal of clinical oncology : official journal of the American Society of Clinical Oncology
researchProduct